Your session is about to expire
← Back to Search
Crisis Response Planning for Suicide Prevention
N/A
Recruiting
Led By Stephanie Gorka, PhD
Research Sponsored by Ohio State University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Age 18 years or older at the time of consent
Be older than 18 years old
Must not have
Medical or neurologic condition or neurocognitive dysfunction that would interfere with the study
Under 18 years old at the time of enrollment
Timeline
Screening 3 weeks
Treatment Varies
Follow Up pre-treatment, post-treatment, 1-week post-intervention, monthly post-intervention, and 6-months post-intervention.
Awards & highlights
No Placebo-Only Group
Summary
This trial tests if a one-hour session of Crisis Response Planning (CRP) can help adults with suicidal thoughts by giving them a personalized plan to manage their feelings. The study compares CRP to other methods to see which is more effective in reducing suicide risk over time.
Who is the study for?
Adults with current suicidal intent, as indicated by a score of 5 or more on the Beck's Scale for Suicidal Ideation. Participants must be generally healthy and able to give informed consent. Excluded are those with certain mental health conditions, pregnant women, individuals under drug influence during scans, people uncomfortable in small spaces, non-English speakers, and anyone with metal implants.
What is being tested?
The study compares two suicide prevention strategies: a one-hour session of Crisis Response Planning (CRP) versus standard crisis risk management. The impact on emotion regulation and suicide risk is assessed immediately after and six months post-intervention. Daily mood checks occur for the first ten days then monthly up to six months.
What are the potential side effects?
Since this trial involves counseling interventions rather than medications or medical procedures, traditional side effects are not applicable. However, participants may experience emotional discomfort discussing sensitive topics like suicidality.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I am 18 years old or older.
Exclusion Criteria
You may be eligible for the trial if you check “No” for criteria below:Select...
I do not have any health conditions that would affect my participation in the study.
Select...
I am younger than 18.
Select...
I have had a traumatic brain injury from a suicide attempt or another event.
Select...
I am deaf in one or both ears.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ pre-treatment, post-treatment, 1-week post-intervention, monthly post-intervention, and 6-months post-intervention.
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~pre-treatment, post-treatment, 1-week post-intervention, monthly post-intervention, and 6-months post-intervention.
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Frontolimbic neural circuit activation and connectivity
Suicidality
Secondary study objectives
Markers of negative affectivity
Mood and psychiatric symptoms
Awards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
3Treatment groups
Experimental Treatment
Active Control
Group I: Crisis Response Planning (CRP)Experimental Treatment1 Intervention
The crisis response planning (CRP) session will last between 30 minutes to 1-hour. It will occur face-to-face with a trained study therapist. The CRP session involves the following standard suicide intervention strategies: supportive listening, provision of crisis resources, and referral to a mental health professional (if not already established). The CRP active component involves a collaborative process in which the therapist invites the patient to share the events, symptoms, and contextual factors leading up to and surrounding the participant's suicidal crisis. Next, the patient and therapist identify the patient's personal warning signs for an emotional crisis, self-management coping skills, patient's reasons for living, and sources of social support. These components are written, by the patient, on an index card. The index card serves as a concrete reference for patients in the real-world.
Group II: ControlActive Control1 Intervention
Individuals who have not experienced suicidal ideation will not complete a suicide intervention.
Group III: Crisis Risk CounselingActive Control1 Intervention
The crisis risk counseling session will last between 30 minutes to 1-hour. It will occur face-to-face with a trained study therapist. It will include the following standard suicide intervention strategies: supportive listening, provision of crisis resources, and referral to a mental health professional (if not already established). The therapist will conduct a semi-structured suicide risk assessment interview, after which subjects will complete a self-guided safety plan worksheet. The worksheet takes approximately 10-minutes to complete and will be done independently.
Research Highlights
Information in this section is not a recommendation. We encourage patients to speak with their healthcare team when evaluating any treatment decision.Mechanism Of Action
Side Effect Profile
Prior Approvals
Other Research
Crisis Response Planning (CRP) and similar interventions work by providing structured planning and coping strategies to manage crises. These treatments involve identifying personal warning signs, developing internal coping mechanisms, and creating a list of contacts and resources for support during a crisis.
This approach is crucial for suicide patients as it helps reduce immediate risk by offering concrete steps to follow during moments of acute distress, thereby enhancing their sense of control and preparedness. By having a clear plan, patients can better manage their emotions and reduce the likelihood of acting on suicidal impulses.
Find a Location
Who is running the clinical trial?
Ohio State UniversityLead Sponsor
871 Previous Clinical Trials
655,781 Total Patients Enrolled
19 Trials studying Suicide
42,192 Patients Enrolled for Suicide
Stephanie Gorka, PhDPrincipal InvestigatorOhio State University
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I do not have any health conditions that would affect my participation in the study.I have had a traumatic brain injury from a suicide attempt or another event.I am younger than 18.I am deaf in one or both ears.I have not had electroconvulsive therapy in the last 6 months.I am generally healthy without major medical or neurological issues.I am 18 years old or older.
Research Study Groups:
This trial has the following groups:- Group 1: Control
- Group 2: Crisis Response Planning (CRP)
- Group 3: Crisis Risk Counseling
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.